Follow on Google News News By Tag * Pre-filled Syringes * Medical Devices * Syringes * Syringe Packing * Pre-filled Medical Devices * More Tags... Industry News News By Location Country(s) Industry News
Follow on Google News | Brand new Pre-Filled Syringes and Related Systems: World Market Outlook 2010-2025 reportThe market for pre-filled syringes has achieved growth in recent years. In 2009, an estimated 2 billion pre-filled syringe units were sold and the market for that technology was estimated to be worth up to $2.5 billion.
By: Visiongain Ltd. – how will rising demand and technological developments create opportunities? The market for pre-filled syringes has achieved growth in recent years. In 2009, an estimated 2 billion pre-filled syringe units were sold and the market for that technology was estimated to be worth up to $2.5 billion. There is a trend towards pre-filled drug injection systems, away from vials/ampules, for both new and existing products. Examples are filled glass and plastic syringes, pens and low-volume auto-injection devices, including refills. That sector has shown growth of 10-15% in recent years, forming one of the fastest-expanding sectors in the pharmaceutical industry. In our new report, we predict that the pre-filled drug delivery market will grow steadily from 2010, as the number of products launched in pre-filled injectable forms increases. Medical professionals, patients and other stakeholders see the benefits of that more-convenient system, raising demand at the expense of older formats. Pre-Filled Syringes and Related Systems: World Market Outlook 2010-2025 shows how a range of therapeutic agents – vaccines, insulins, analogues and many other biologicals – drive growth in that sector. Combined with new pre-filled drug delivery systems and healthcare safety and cost-saving initiatives, the market for pre-filled syringes and similar devices will expand steadily. All the therapeutic segments using pre-filled injectables have been growing in revenue, but which will expand fastest in future? What are the therapeutic and commercial trends to watch? How will the global market for pre-filled syringe-type products perform from 2010 to 2025? Our report answers such questions, providing the information that you need. The range of pre-filled syringes and related products has broadened into many areas, including: • Vaccines • Anti-coagulants • Anti-infectives • Anti-inflammatory agents • Haematological agents • Multiple sclerosis therapies • Hormone therapies • Obstetric agents • Cancer therapies • Pain relievers. The pharmaceutical industry accepts pre-filled drug technology as a proven market and the format of choice for many parentally-administered drugs. Because a product’s delivery system can affect patient compliance – influencing therapeutic outcomes, cost-effectiveness and brand image – easier-to-use devices can confer higher sales and market share. Our new report shows how partnerships between companies will be crucial when developing and harnessing pre-filled injection technologies. Detailed analysis of the pre-filled drug delivery industry and market Pre-Filled Syringes and Related Systems: World Market Outlook 2010-2025 examines that sector through a comprehensive review of information sources. We use primary and secondary research. This report provides unique sales forecasts, market share analyses, discussions of R&D pipeline developments and analyses of commercial drivers and restraints, including SWOT analysis. There are over 110 tables and figures included, as well as two interviews with experts. The result is a comprehensive market- and industry-centred study, with detailed analyses and informed opinion to benefit your work. This primary research is not available anywhere else - so to benefit from this you must read this report. Why you should buy Pre-Filled Syringes and Related Systems: World Market Outlook 2010-2025 This report gives you the following benefits in particular: • You will receive a comprehensive analysis of the prospects for pre-filled syringe devices, including predicted revenues and other data, by therapeutic category and leading brand • You will find out how the pre-filled devices market will change from 2010 to 2025, with sales forecasts for the global market and leading national markets (US, Japan, UK, Germany, France, Spain, Italy, China and India) • You will discover how the pre-filled drug device sector is evolving to deliver improved ease of use, safety, product stability and patient compliance • You will discover why legislation is one of the most important drivers of demand for pre-filled injection technology and products • You will analyse the drivers, restraints, competition and opportunities influencing the pre-filled injection devices industry and market • You will investigate R&D developments in that sector, with up-and-coming trends highlighted • You will examine interviews with experts regarding current and future trends, opportunities and commercial drivers in the sector • You will find out how the pre-filled syringes industry and market are progressing worldwide – technologically and commercially – and what the future holds. You can obtain this report today Nobody with an interest in the parenteral drug sector should overlook our new study. Success in the pre-filled drug devices market from 2010 onwards will be characterised by products with superior delivery of high-value biotechnological drugs. Stability, safety, convenience and cost-effectiveness will increase. Rising disease prevalence – coupled with benefits to pharma stakeholders – are drivers of this market. Do you want to harness those opportunities? Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6 Contact Person Bijal Patel bijal.patel@ Direct Line: +44 (0)20 7549 9946 +44 (0)20 7336 6100 # # # Visiongain is an independent business information provider for the Telecoms, Pharmaceutical and Defence industries. We organise conferences, publish reports and newsletters, and provide consultancy services. End
Account Email Address Disclaimer Report Abuse Page Updated Last on: May 06, 2010
|
|